Apyx Medical (APYX) Competitors $2.09 +0.04 (+1.95%) Closing price 04:00 PM EasternExtended Trading$2.09 0.00 (0.00%) As of 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APYX vs. NPCE, CLPT, NNOX, SKIN, ZIMV, BSGM, SNWV, DRTS, NYXH, and SMTIShould you be buying Apyx Medical stock or one of its competitors? The main competitors of Apyx Medical include NeuroPace (NPCE), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), Beauty Health (SKIN), ZimVie (ZIMV), Biosig Technologies (BSGM), Sanuwave Health (SNWV), Alpha Tau Medical (DRTS), Nyxoah (NYXH), and Sanara MedTech (SMTI). These companies are all part of the "medical equipment" industry. Apyx Medical vs. Its Competitors NeuroPace ClearPoint Neuro Nano-X Imaging Beauty Health ZimVie Biosig Technologies Sanuwave Health Alpha Tau Medical Nyxoah Sanara MedTech NeuroPace (NASDAQ:NPCE) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Which has more volatility and risk, NPCE or APYX? NeuroPace has a beta of 1.93, suggesting that its share price is 93% more volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.31, suggesting that its share price is 31% more volatile than the S&P 500. Do analysts prefer NPCE or APYX? NeuroPace currently has a consensus target price of $17.00, indicating a potential upside of 86.61%. Given NeuroPace's stronger consensus rating and higher possible upside, equities research analysts plainly believe NeuroPace is more favorable than Apyx Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroPace 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 Do insiders and institutionals believe in NPCE or APYX? 78.8% of NeuroPace shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 20.5% of NeuroPace shares are held by insiders. Comparatively, 15.2% of Apyx Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media refer more to NPCE or APYX? In the previous week, NeuroPace and NeuroPace both had 1 articles in the media. NeuroPace's average media sentiment score of 1.89 beat Apyx Medical's score of 1.87 indicating that NeuroPace is being referred to more favorably in the media. Company Overall Sentiment NeuroPace Very Positive Apyx Medical Very Positive Which has higher earnings & valuation, NPCE or APYX? Apyx Medical has lower revenue, but higher earnings than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroPace$79.91M3.74-$27.14M-$0.84-10.85Apyx Medical$47.29M1.67-$23.46M-$0.55-3.80 Is NPCE or APYX more profitable? NeuroPace has a net margin of -29.42% compared to Apyx Medical's net margin of -42.37%. Apyx Medical's return on equity of -156.85% beat NeuroPace's return on equity.Company Net Margins Return on Equity Return on Assets NeuroPace-29.42% -190.84% -25.08% Apyx Medical -42.37%-156.85%-31.92% SummaryNeuroPace beats Apyx Medical on 11 of the 16 factors compared between the two stocks. Get Apyx Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APYX vs. The Competition Export to ExcelMetricApyx MedicalMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$77.48M$10.27B$5.52B$9.32BDividend YieldN/A2.07%4.25%4.05%P/E Ratio-3.8016.9728.1519.68Price / Sales1.6729.20438.32100.43Price / CashN/A22.2335.5357.53Price / Book5.503.598.235.67Net Income-$23.46M$233.40M$3.23B$257.51M7 Day Performance-8.33%-2.69%-0.01%0.52%1 Month Performance12.37%1.85%5.61%8.84%1 Year Performance51.45%-18.53%26.52%14.18% Apyx Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APYXApyx Medical2.2014 of 5 stars$2.09+2.0%N/A+49.6%$77.48M$47.29M-3.80270NPCENeuroPace3.536 of 5 stars$10.22-1.6%$15.50+51.7%+21.4%$340.78M$79.91M-12.17170Positive NewsCLPTClearPoint Neuro1.8226 of 5 stars$11.80+0.9%$25.00+111.9%+48.3%$327.47M$31.39M-15.53110NNOXNano-X Imaging2.5715 of 5 stars$5.12-3.8%$9.50+85.5%-44.7%$307.38M$11.28M-5.69190News CoveragePositive NewsAnalyst UpgradeSKINBeauty Health0.2829 of 5 stars$2.20-3.5%$1.42-35.6%-22.3%$287.27M$334.30M-5.371,030ZIMVZimVie1.9993 of 5 stars$9.43-8.0%$16.33+73.2%-53.8%$285.43M$449.75M-13.281,770BSGMBiosig Technologies1.8903 of 5 stars$11.55+11.0%$10.00-13.4%+955.3%$284.14M$40K0.0050News CoverageHigh Trading VolumeSNWVSanuwave HealthN/A$33.17+4.8%N/AN/A$270.79M$36.19M-7.2840DRTSAlpha Tau Medical3.1262 of 5 stars$3.29+3.8%$8.00+143.2%+48.6%$268.88MN/A-7.1580Positive NewsNYXHNyxoah2.8571 of 5 stars$7.86+1.2%$14.50+84.5%-14.7%$264.65M$4.89M-3.69110Positive NewsSMTISanara MedTech2.5015 of 5 stars$29.17-1.6%$49.50+69.7%-8.2%$263.52M$86.67M-21.7760News CoverageHigh Trading Volume Related Companies and Tools Related Companies NPCE Competitors CLPT Competitors NNOX Competitors SKIN Competitors ZIMV Competitors BSGM Competitors SNWV Competitors DRTS Competitors NYXH Competitors SMTI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APYX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Apyx Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APYX Stock Alerts